欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
EL/H/0353/002
药品名称
XELAZOR
活性成分
Capecitabine 500.0 mg
剂型
Film-coated tablet
上市许可持有人
Vocate Pharmaceuticals S.A. Gounari 150, 166 74 Glifada, Greece
参考成员国 - 产品名称
Greece (GR)
互认成员国 - 产品名称
许可日期
2014/11/05
最近更新日期
2024/12/24
药物ATC编码
L01BC06 capecitabine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
PAB_CAP_inner_labelling_150mg_V01_00
Date of last change:2024/09/06
Final Product Information
|
PAB_CAP_inner_labelling_500mg_V01_00
Date of last change:2024/09/06
Final Product Information
|
PAB_CAP_pl_150_mg_v01_00
Date of last change:2024/09/06
Final Product Information
|
PAB_CAP_pl_500_mg_v01_00
Date of last change:2024/09/06
Final Product Information
|
PAB_CAP_spc_150_mg_v01_00
Date of last change:2024/09/06
Final Product Information
|
PAB_CAP_spc_500mg_v01_00
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase